MCRB (MCRB) Stock Price & Analysis
MCRB (MCRB) rose 1.42% to USD 5.72 as of September 8, 2026 at 09:37 UTC, according to Nexqual real-time market data.
MCRB last closed at USD 5.72; the session ranged USD 5.58–5.89 on volume of 36,447 shares. Market capitalization is —, with a 52-week range of USD 4.32–29.98 (NMS). Source: Nexqual, September 8, 2026 at 09:37 UTC.
Key Statistics (as of September 8, 2026 at 09:37 UTC)
| Price | USD 5.72 |
|---|---|
| Change | ▲ 1.42% (up) |
| Previous Close | USD 5.72 |
| Open | USD 5.72 |
| Day Range | USD 5.58 – 5.89 |
| 52-Week Range | USD 4.32 – 29.98 |
| Volume | 36,447 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MCRB)
Nexqual's technical model rates MCRB "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 09:37 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64.66 (neutral) |
| vs SMA50 | Above (USD 5.47) |
| MACD | 0.07 (positive) |
From MCRB's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
| FATE | Fate Therapeutics, Inc. | USD 2.48 | ▲ 1.22% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:37 UTC. This page is informational and not investment advice.